Differential regulation of BACE1 promoter activity by nuclear factor-κB in neurons and glia upon exposure to β-amyloid peptides

Krystyn Z. Bourne, Diana C. Ferrari, Christine Lange-Dohna, Steffen Roßner, Thomas Wood, J. Regino Perez-Polo

Research output: Contribution to journalArticle

140 Citations (Scopus)

Abstract

The brains of Alzheimer's disease (AD) patients display cerebrovascular and parenchymal deposits of β-amyloid (Aβ) peptides, which are derived by proteolytic processing by the β-site APP-cleaving enzyme 1 (BACE1) of the amyloid precursor protein (APP). The rat BACE1 promoter has a nuclear factor-κB (NF-κB) binding site. Deletion studies with a BACE1 promoter/luciferase reporter suggest that the NF-κB binding DNA consensus sequence plays a suppressor role, when occupied by NF-κB, in the regulation of neuronal brain BACE1 expression. Here we characterize a signal transduction pathway that may be responsible for the increases in Aβ associated with AD. We propose that the transcription factor NF-κB acts as a repressor in neurons but as an activator of BACE1 transcription in activated astrocytes present in the CNS under chronic stress, a feature present in the AD brain. The activated astrocytic stimulation of BACE1 may in part account for increased BACE1 transcription and subsequent processing of Aβ in a cell-specific manner in the aged and AD brain. As measured by reporter gene promoter constructs and endogenous BACE1 protein expression, a functional NF-κB site was stimulatory in activated astrocytes and Aβ-exposed neuronal cells and repressive in neuronal and nonactivated astrocytic cells. Given the evidence for increased levels of activated astrocytes in the aged brain, the age- and AD-associated increases in NF-κB in brain may be significant contributors to increases in Aβ, acting as a positive feedback loop of chronic inflammation, astrocyte activation, increased p65/p50 activation of BACE1 transcription, and further inflammation.

Original languageEnglish (US)
Pages (from-to)1194-1204
Number of pages11
JournalJournal of Neuroscience Research
Volume85
Issue number6
DOIs
StatePublished - May 1 2007

Fingerprint

Amyloid
Neuroglia
Neurons
Peptides
Enzymes
Alzheimer Disease
Astrocytes
Amyloid beta-Protein Precursor
Brain
Brain Diseases
Inflammation
Amyloid Plaques
Consensus Sequence
Luciferases
Reporter Genes
Signal Transduction
Transcription Factors
Binding Sites

Keywords

  • Alzheimer's disease
  • Astrocytes
  • BACE1
  • NF-κB

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Differential regulation of BACE1 promoter activity by nuclear factor-κB in neurons and glia upon exposure to β-amyloid peptides. / Bourne, Krystyn Z.; Ferrari, Diana C.; Lange-Dohna, Christine; Roßner, Steffen; Wood, Thomas; Perez-Polo, J. Regino.

In: Journal of Neuroscience Research, Vol. 85, No. 6, 01.05.2007, p. 1194-1204.

Research output: Contribution to journalArticle

Bourne, Krystyn Z. ; Ferrari, Diana C. ; Lange-Dohna, Christine ; Roßner, Steffen ; Wood, Thomas ; Perez-Polo, J. Regino. / Differential regulation of BACE1 promoter activity by nuclear factor-κB in neurons and glia upon exposure to β-amyloid peptides. In: Journal of Neuroscience Research. 2007 ; Vol. 85, No. 6. pp. 1194-1204.
@article{110ca78b748f4a2b94333fcc55a8c8b9,
title = "Differential regulation of BACE1 promoter activity by nuclear factor-κB in neurons and glia upon exposure to β-amyloid peptides",
abstract = "The brains of Alzheimer's disease (AD) patients display cerebrovascular and parenchymal deposits of β-amyloid (Aβ) peptides, which are derived by proteolytic processing by the β-site APP-cleaving enzyme 1 (BACE1) of the amyloid precursor protein (APP). The rat BACE1 promoter has a nuclear factor-κB (NF-κB) binding site. Deletion studies with a BACE1 promoter/luciferase reporter suggest that the NF-κB binding DNA consensus sequence plays a suppressor role, when occupied by NF-κB, in the regulation of neuronal brain BACE1 expression. Here we characterize a signal transduction pathway that may be responsible for the increases in Aβ associated with AD. We propose that the transcription factor NF-κB acts as a repressor in neurons but as an activator of BACE1 transcription in activated astrocytes present in the CNS under chronic stress, a feature present in the AD brain. The activated astrocytic stimulation of BACE1 may in part account for increased BACE1 transcription and subsequent processing of Aβ in a cell-specific manner in the aged and AD brain. As measured by reporter gene promoter constructs and endogenous BACE1 protein expression, a functional NF-κB site was stimulatory in activated astrocytes and Aβ-exposed neuronal cells and repressive in neuronal and nonactivated astrocytic cells. Given the evidence for increased levels of activated astrocytes in the aged brain, the age- and AD-associated increases in NF-κB in brain may be significant contributors to increases in Aβ, acting as a positive feedback loop of chronic inflammation, astrocyte activation, increased p65/p50 activation of BACE1 transcription, and further inflammation.",
keywords = "Aβ, Alzheimer's disease, Astrocytes, BACE1, NF-κB",
author = "Bourne, {Krystyn Z.} and Ferrari, {Diana C.} and Christine Lange-Dohna and Steffen Ro{\ss}ner and Thomas Wood and Perez-Polo, {J. Regino}",
year = "2007",
month = "5",
day = "1",
doi = "10.1002/jnr.21252",
language = "English (US)",
volume = "85",
pages = "1194--1204",
journal = "Journal of Neuroscience Research",
issn = "0360-4012",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Differential regulation of BACE1 promoter activity by nuclear factor-κB in neurons and glia upon exposure to β-amyloid peptides

AU - Bourne, Krystyn Z.

AU - Ferrari, Diana C.

AU - Lange-Dohna, Christine

AU - Roßner, Steffen

AU - Wood, Thomas

AU - Perez-Polo, J. Regino

PY - 2007/5/1

Y1 - 2007/5/1

N2 - The brains of Alzheimer's disease (AD) patients display cerebrovascular and parenchymal deposits of β-amyloid (Aβ) peptides, which are derived by proteolytic processing by the β-site APP-cleaving enzyme 1 (BACE1) of the amyloid precursor protein (APP). The rat BACE1 promoter has a nuclear factor-κB (NF-κB) binding site. Deletion studies with a BACE1 promoter/luciferase reporter suggest that the NF-κB binding DNA consensus sequence plays a suppressor role, when occupied by NF-κB, in the regulation of neuronal brain BACE1 expression. Here we characterize a signal transduction pathway that may be responsible for the increases in Aβ associated with AD. We propose that the transcription factor NF-κB acts as a repressor in neurons but as an activator of BACE1 transcription in activated astrocytes present in the CNS under chronic stress, a feature present in the AD brain. The activated astrocytic stimulation of BACE1 may in part account for increased BACE1 transcription and subsequent processing of Aβ in a cell-specific manner in the aged and AD brain. As measured by reporter gene promoter constructs and endogenous BACE1 protein expression, a functional NF-κB site was stimulatory in activated astrocytes and Aβ-exposed neuronal cells and repressive in neuronal and nonactivated astrocytic cells. Given the evidence for increased levels of activated astrocytes in the aged brain, the age- and AD-associated increases in NF-κB in brain may be significant contributors to increases in Aβ, acting as a positive feedback loop of chronic inflammation, astrocyte activation, increased p65/p50 activation of BACE1 transcription, and further inflammation.

AB - The brains of Alzheimer's disease (AD) patients display cerebrovascular and parenchymal deposits of β-amyloid (Aβ) peptides, which are derived by proteolytic processing by the β-site APP-cleaving enzyme 1 (BACE1) of the amyloid precursor protein (APP). The rat BACE1 promoter has a nuclear factor-κB (NF-κB) binding site. Deletion studies with a BACE1 promoter/luciferase reporter suggest that the NF-κB binding DNA consensus sequence plays a suppressor role, when occupied by NF-κB, in the regulation of neuronal brain BACE1 expression. Here we characterize a signal transduction pathway that may be responsible for the increases in Aβ associated with AD. We propose that the transcription factor NF-κB acts as a repressor in neurons but as an activator of BACE1 transcription in activated astrocytes present in the CNS under chronic stress, a feature present in the AD brain. The activated astrocytic stimulation of BACE1 may in part account for increased BACE1 transcription and subsequent processing of Aβ in a cell-specific manner in the aged and AD brain. As measured by reporter gene promoter constructs and endogenous BACE1 protein expression, a functional NF-κB site was stimulatory in activated astrocytes and Aβ-exposed neuronal cells and repressive in neuronal and nonactivated astrocytic cells. Given the evidence for increased levels of activated astrocytes in the aged brain, the age- and AD-associated increases in NF-κB in brain may be significant contributors to increases in Aβ, acting as a positive feedback loop of chronic inflammation, astrocyte activation, increased p65/p50 activation of BACE1 transcription, and further inflammation.

KW - Aβ

KW - Alzheimer's disease

KW - Astrocytes

KW - BACE1

KW - NF-κB

UR - http://www.scopus.com/inward/record.url?scp=34248178463&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248178463&partnerID=8YFLogxK

U2 - 10.1002/jnr.21252

DO - 10.1002/jnr.21252

M3 - Article

C2 - 17385716

AN - SCOPUS:34248178463

VL - 85

SP - 1194

EP - 1204

JO - Journal of Neuroscience Research

JF - Journal of Neuroscience Research

SN - 0360-4012

IS - 6

ER -